维普期刊资源整合服务平台（V6.5）

548篇 您的检索式：作者名="ESCUDIE B"

选中清除导出查看参考文献查看引证文献引用追踪共28页首页上一页第1页下一页末页 /28 跳转

	题名	作者	年代	出处	被引量
1	Comparative ef-fectiveness of axitinib versus sorafenib in advanced renal cell car-cinoma( AXIS) : a randomised phase 3 trial显示文摘	RINI BI ESCUDIER B TOMCZAK P	2011	Lancet2011，378，9807：	1
2	Efficacy ofeverolimus in advanced renal cell carcinoma : a double,Blind randomised, placebo controlled phase HI trial显示文摘	Motzer R J Escudier B Oudard S	2008	Lancet2008，372，44：	1
3	Prospective study of the cuta-neous adverse effects of sorafenib,a novel multikinase inhibitor显示文摘	Autier J Escudier B Wechsler J	2008	Arch Dermatol2008，144，7：	1
4	Randomized PhaseⅢ trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC) 显示文摘	Escudier B Szczylik C Eisen T	2005	J Clin Oncology2005，，：	1
5	Sorafenib in advanced clear-cell renal -cell carcinoma 显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl JMed2007，356，2：	1
6	A 10-year clinical experience with intermittent hormonal therapy for prostate cancer显示文摘	Prapotnich D Fizazi K Escudier B	2003	Eur Urol2003，43，：	1
7	Axitinib versus sorafenib as second - line therapy for metastatic renal cell carcinoma (mRCC) :results of phase Ⅲ AXIS trial 显示文摘	Rini BI Escudier B Tomczak P	2011	In ASCO Meeting Abstracts2011，，：	1
8	Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，：	1
9	Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy:new paradigm from a large phase Ill trial with shark cartilage extract AE 941 显示文摘	Escudier B Choueiri T K Oudard S	2007	J Urol2007，178，5：	1
10	Asymptotic wavelet and gabor analysis: extraction of instantaneous frequencies 显示文摘	Delprat N Escudie B Guillemain P	1992	IEEE Transactions on Information Theory1992，38，2：	1
11	Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes : results of thefirst phase 1 clinical trial 显示文摘	Escudier B	2005	J Transl Med2005，3，1：	1
12	Sorafenib in advanced clearcell renal cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
13	Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up显示文摘	Escudier B Kataja V	2009	Annals of Oncology2009，20，4：	1
14	Phase 3 Trial of everolimus for metastatic renal cell carcinoma 显示文摘	MOTZER RJ ESCUDIER B OUDARD S	2010	Cancer2010，116，18：	1
15	Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
16	Asymptotic wavelet and gabor analysis: extraction of instantaneous frequencies显示文摘	DelpratN Escudie B GuillemainP	1992	IEEE Trans on Information Theory1992，38，2：	1
17	A lO-year clinical experience with intermittent hormonal therapy for prostate cancer显示文摘	PRAPOTNICH D FIZAZI K ESCUDIER B	2003	Ear Ural Mar2003，43，3：	1
18	Asymptotic wavelet and Gabor analysis: Extraction of instantaneous frequencies显示文摘	Delprat N Escudie B Guillemain P	1992	IEEE Trans on Information Theory1992，38，2：	1
19	Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase UI trials显示文摘	Miles D Harbeck N Escudier B	2011	J Clin Oncol2011，，：	1
20	Sorafenib fortreatment of renal cell carcinoma: Final efficacy and safety results of the phase m treatment approaches in renal cancer global evaluation triaI显示文摘	Escudier B Eisen T Stadler WM	2009	) Clin Oneol2009，27，20：	1

返回顶部每页显示：

共28页首页上一页第1页下一页末页 /28 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示